Prof. Dr. Rainer Fietkau

Medizinische Fakultät Lehrstuhl für Strahlentherapie

Improved survival for elderly married glioblastoma patients : Better treatment delivery, less toxicity, and fewer disease complications (2016) Putz F, Putz T, Goerig N, Knippen S, Gryc T, Eyüpoglu IY, Roessler K, et al. Journal article Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results (2016) Gryc T, Ott O, Putz F, Knippen S, Raptis D, Fietkau R, Strnad V Journal article GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance (2016) Ott OJ, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, et al. Journal article Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry (2016) Rühle PF, Fietkau R, Gaipl U, Frey B Journal article Re-irradiation of the chest wall for local breast cancer recurrence : Results of salvage brachytherapy with hyperthermia (2016) Auoragh A, Strnad V, Ott OJ, Beckmann M, Fietkau R Journal article Optimization of Single Voxel MR Spectroscopy Sequence Parameters and Data Analysis Methods for Thermometry in Deep Hyperthermia Treatments (2016) Hartmann J, Gellermann J, Brandt T, Schmidt M, Pyatykh S, Hesser J, Ott O, et al. Journal article High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype (2016) Haderlein M, Scherl C, Semrau S, Lettmaier S, Uter W, Neukam FW, Iro H, et al. Journal article Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy (2016) Manapov F, Niyazi M, Gerum S, Roengvoraphoj O, Eze C, Li M, Hildebrandt G, et al. Journal article How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life Experience (2016) Sikic D, Wach S, Taubert H, Richterstetter M, Kunath F, Lieb V, Krause FS, et al. Journal article GILT - A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer (2016) Flentje M, Huber RM, Engel-Riedel W, Andreas S, Kollmeier J, Staar S, Dickgreber N, et al. Journal article